Bacher, et al v. Boehringer Ingelheim Pharmaceuticals, Inc., et al
Beth Bacher, Representative for Paul Bacher (Deceased), Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost, Plaintiff Representative for Richard Yost (Deceased) |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. |
23-877 |
June 13, 2023 |
U.S. Court of Appeals, Second Circuit |
Torts |
Docket Report
This docket was last retrieved on July 18, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 220 JOINDER LETTER, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, confirming they join in the brief filed by Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, RECEIVED. Service date 07/18/2023 by CM/ECF.[3543283] [23-877]--[Edited 07/18/2023 by RW] [Entered: 07/18/2023 03:35 PM] |
Filing 219 JOINDER LETTER, on behalf of Appellant Pfizer, Inc., confirming they join in the brief filed by Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC., RECEIVED. Service date 07/18/2023 by CM/ECF.[3543241] [23-877]--[Edited 07/18/2023 by RW] [Entered: 07/18/2023 02:53 PM] |
Filing 218 CURED DEFECTIVE JOINT APPENDIX, volumes 1-5, [ # 211 ], [ # 212 ], [ # 213 ], [ # 214 ], [ # 215 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543230] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:46 PM] |
Filing 217 CURED DEFECTIVE BRIEF & SPECIAL APPENDIX, [ # 210 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543227] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:44 PM] |
Filing 216 MOTION ORDER, granting motion to adjourn oral argument [ # 206 ] filed by Appellant Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. in 23-877, FILED. [3543211][216] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:35 PM] |
Filing 215 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543205] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:30 PM] |
Filing 214 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543199] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:28 PM] |
Filing 213 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543196] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:24 PM] |
Filing 212 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543192] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:21 PM] |
Filing 211 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543189] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:19 PM] |
Filing 210 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543185] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:15 PM] |
Filing 209 JOINDER LETTER, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, confirming they join in the brief filed by Appellant Sanofi US Services, Inc. and Sanofi-Aventis U.S. LLC., RECEIVED. Service date 07/18/2023 by CM/ECF.[3543177] [23-877]--[Edited 07/18/2023 by RW] [Entered: 07/18/2023 02:06 PM] |
Filing 207 CURED DEFECTIVE MOTION, TO ADJOURN ORAL ARGUMENT, [ # 206 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543083] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:56 PM] |
Filing 206 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543073] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:52 PM] |
Filing 202 DEFECTIVE DOCUMENT, Joint Appendix, volumes 1-5, [193], [194], [195], [196], [197], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542873] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:17 AM] |
Filing 201 DEFECTIVE DOCUMENT, Brief & Special Appendix, [192], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542867] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:06 AM] |
Filing 200 DEFECTIVE DOCUMENT, MOTION, to adjourn oral argument, [198], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542842] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 08:43 AM] |
Filing 198 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542754] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885]--[Edited 07/18/2023 by RW] [Entered: 07/17/2023 08:06 PM] |
Filing 197 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542747] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:19 PM] |
Filing 196 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542746] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:15 PM] |
Filing 195 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542745] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:13 PM] |
Filing 194 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542744] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:10 PM] |
Filing 193 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542743] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:08 PM] |
Filing 192 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542742] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:05 PM] |
Filing 191 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-877, [ # 53 ], ADDED.[3541589] [23-877] [Entered: 07/14/2023 11:22 AM] |
Filing 190 ATTORNEY, Robert A. Izard Jr. for Armando Ramos, in case 23-879, [ # 3537336-2 ], ADDED.[3541566] [23-879] [Entered: 07/14/2023 11:01 AM] |
Filing 189 ATTORNEY, Craig Archer Raabe for Armando Ramos, in case 23-879, [ # 3537246-2 ], ADDED.[3541563] [23-879] [Entered: 07/14/2023 11:00 AM] |
Filing 188 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, [ # 3537246-2 ], [ # 3537336-2 ], on behalf of Appellee Armando Ramos, FILED.[3541562] [23-879] [Entered: 07/14/2023 10:58 AM] |
Filing 184 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-878 , [ # 3534547-2 ], ADDED.[3541453] [23-878] [Entered: 07/14/2023 09:39 AM] |
Filing 181 NEW CASE MANAGER, Ronald Willoughby, ASSIGNED.[3541402] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/14/2023 08:45 AM] |
Filing 168 ATTORNEY, Robert A. Izard Jr. for John Corwin, in case 23-881, [ # 3537370-2 ], ADDED.[3541238] [23-881] [Entered: 07/13/2023 04:58 PM] |
Filing 164 CURED DEFECTIVE Notice of Appearance as Additional Counsel, [ # 119 ], [ # 3537259-2 ], on behalf of Appellee John Corwin, FILED.[3541231] [23-881] [Entered: 07/13/2023 04:55 PM] |
Filing 160 ATTORNEY, Robert A. Izard Jr. for Mary Cassidy, in case 23-880 , [ # 3537356-2 ], ADDED.[3541215] [23-880] [Entered: 07/13/2023 04:49 PM] |
Filing 156 CURED DEFECTIVE Notice of Appearance as Additional Counsel, [ # 119 ], [ # 3537255-2 ], on behalf of Appellee Mary Cassidy, FILED.[3541206] [23-880] [Entered: 07/13/2023 04:46 PM] |
Filing 152 ATTORNEY, Robert A. Izard Jr. for Jerome Jay Berkowitz, in case 23-878, [ # 3537352-2 ], ADDED.[3541191] [23-878] [Entered: 07/13/2023 04:37 PM] |
Filing 146 ATTORNEY, Robert A. Izard Jr. for Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano, Anne Yost, in case 23-877, [ # 128 ], ADDED.[3540660] [23-877]--[Edited 07/14/2023 by RW] [Entered: 07/12/2023 05:06 PM] |
Filing 144 CURED DEFECTIVE Notice of Appearance as Additional Counsel, [ # 119 ], [ # 3537253-2 ], on behalf of Appellee Jerome Jay Berkowitz, FILED.[3539791] [23-878] [Entered: 07/11/2023 12:21 PM] |
Filing 142 CURED DEFECTIVE Notice of Appearance as Additional Counsel, [ # 119 ], [ # 124 ], on behalf of Appellee Beth Bacher, FILED.[3539785] [23-877] [Entered: 07/11/2023 12:12 PM] |
Filing 141 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, [ # 3537251-2 ], [ # 3537348-2 ], on behalf of Appellee Anne Yost, FILED.[3539741] [23-885] [Entered: 07/11/2023 11:13 AM] |
Filing 140 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, [ # 3537264-2 ], [ # 3537376-2 ], on behalf of Appellee Thomas Vazzano, FILED.[3539740] [23-882] [Entered: 07/11/2023 11:10 AM] |
Filing 131 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-881, [ # 3535098-2 ], ADDED.[3538105] [23-881] [Entered: 07/06/2023 04:07 PM] |
Filing 130 ATTORNEY, Robert A. Izard Jr. for Anne Yost, in case 23-885, [ # 3537348-2 ], ADDED.[3537541] [23-885] [Entered: 07/05/2023 05:51 PM] |
Filing 129 ATTORNEY, Robert A. Izard Jr. for Thomas Vazzano, in case 23-882, [ # 3537376-2 ], ADDED.[3537540] [23-882] [Entered: 07/05/2023 05:50 PM] |
Filing 128 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, FILED. Service date 07/05/2023 by CM/ECF. [3537332] [23-877] [Entered: 07/05/2023 04:00 PM] |
Filing 126 ATTORNEY, Craig Archer Raabe for Thomas Vazzano, in case 23-882, [ # 3537264-2 ], ADDED.[3537265] [23-882] [Entered: 07/05/2023 03:05 PM] |
Filing 125 ATTORNEY, Craig Archer Raabe for Anne Yost, in case 23-885, [ # 3537251-2 ], ADDED.[3537254] [23-885] [Entered: 07/05/2023 02:54 PM] |
Filing 124 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, FILED. Service date 07/05/2023 by CM/ECF. [3537244] [23-877] [Entered: 07/05/2023 02:45 PM] |
Filing 120 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 100 ], on behalf of Appellee Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED.[3537032] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:21 AM] |
Filing 119 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 99 ], on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, FILED.[3537005] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:09 AM] |
Filing 113 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-881, [ # 3534566-2 ], ADDED.[3536520] [23-881] [Entered: 06/30/2023 02:59 PM] |
Filing 112 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-881, [ # 3534444-2 ], ADDED.[3536512] [23-881] [Entered: 06/30/2023 02:54 PM] |
Filing 108 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-880, [ # 3535092-2 ], ADDED.[3536386] [23-880] [Entered: 06/30/2023 12:55 PM] |
Filing 107 CURED DEFECTIVE Form D, [ # 47 ], [ # 3535077-2 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3536382] [23-880] [Entered: 06/30/2023 12:53 PM] |
Filing 106 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-878, [ # 3535086-2 ], ADDED.[3536379] [23-878] [Entered: 06/30/2023 12:50 PM] |
Filing 104 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, [ # 3535245-2 ], on behalf of Appellants GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3536243] [23-885] [Entered: 06/30/2023 10:59 AM] |
Filing 102 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, [ # 3535240-2 ], on behalf of Appellants GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3536239] [23-882] [Entered: 06/30/2023 10:57 AM] |
Filing 101 CURED DEFECTIVE Form C [ # 93 ], [ # 3535731-2 ], on behalf of Appellant Pfizer, Inc., FILED.[3535780] [23-883] [Entered: 06/29/2023 02:22 PM] |
Filing 100 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535620] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 12:04 PM] |
Filing 99 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535610] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 11:49 AM] |
Filing 97 ATTORNEY, Joseph W. Martini for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-883, [ # 3534254-2 ], ADDED.[3535490] [23-883] [Entered: 06/29/2023 09:40 AM] |
Filing 96 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-883, [ # 3534452-2 ], ADDED.[3535485] [23-883] [Entered: 06/29/2023 09:37 AM] |
Filing 95 ATTORNEY, Anand Agneshwar for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-883, [ # 3534518-2 ], ADDED.[3535479] [23-883] [Entered: 06/29/2023 09:35 AM] |
Filing 94 ATTORNEY, Daniel S. Pariser for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-883, [ # 3534532-2 ], ADDED.[3535472] [23-883] [Entered: 06/29/2023 09:31 AM] |
Filing 93 DEFECTIVE DOCUMENT, Form C, [ # 3534576-2 ], on behalf of Appellant Pfizer, Inc., FILED.[3535454] [23-883] [Entered: 06/29/2023 09:21 AM] |
Filing 92 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL [ # 91 ], [ # 3535264-2 ], on behalf of Appellant GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3535446] [23-883] [Entered: 06/29/2023 09:15 AM] |
Filing 91 DEFECTIVE DOCUMENT, NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL, [ # 3534577-2 ], on behalf of Appellant GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3535437] [23-883] [Entered: 06/29/2023 09:09 AM] |
Filing 90 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-883, [ # 3534579-2 ], ADDED.[3535425] [23-883] [Entered: 06/29/2023 09:00 AM] |
Filing 89 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-883, [ # 3535108-2 ], ADDED.[3535418] [23-883] [Entered: 06/29/2023 08:56 AM] |
Filing 88 ATTORNEY, Lindsey Cohan for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-883, [ # 3535264-2 ], ADDED.[3535417] [23-883] [Entered: 06/29/2023 08:54 AM] |
Filing 87 ELECTRONIC INDEX, in lieu of record, FILED.[3535413] [23-884] [Entered: 06/29/2023 08:47 AM] |
Filing 86 ATTORNEY, Joseph W. Martini for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-884, [ # 3534255-2 ], ADDED.[3535404] [23-884] [Entered: 06/29/2023 08:38 AM] |
Filing 85 ATTORNEY, Robert R. Simpson for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-884, [ # 3534418-2 ], ADDED.[3535402] [23-884] [Entered: 06/29/2023 08:36 AM] |
Filing 84 ATTORNEY, Anand Agneshwar for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-884, [ # 3534424-2 ], ADDED.[3535401] [23-884] [Entered: 06/29/2023 08:34 AM] |
Filing 83 ATTORNEY, Daniel S. Pariser for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-884, [ # 3534435-2 ], ADDED.[3535398] [23-884] [Entered: 06/29/2023 08:32 AM] |
Filing 82 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-884, [ # 3534458-2 ], ADDED.[3535397] [23-884] [Entered: 06/29/2023 08:31 AM] |
Filing 81 DEFECTIVE DOCUMENT, Form C, [ # 3534583-2 ], on behalf of Appellant Pfizer, Inc., FILED.[3535393] [23-884] [Entered: 06/29/2023 08:23 AM] |
Filing 80 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-884, [ # 3534586-2 ], ADDED.[3535391] [23-884] [Entered: 06/29/2023 08:21 AM] |
Filing 79 CURED DEFECTIVE NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL [ # 78 ], [ # 3535267-2 ], on behalf of Appellant GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3535387] [23-884] [Entered: 06/29/2023 08:07 AM] |
Filing 78 DEFECTIVE DOCUMENT, NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL, [ # 3534598-2 ], on behalf of Appellant GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3535386] [23-884] [Entered: 06/29/2023 08:00 AM] |
Filing 77 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-884, [ # 3535111-2 ], ADDED.[3535385] [23-884] [Entered: 06/29/2023 07:58 AM] |
Filing 76 ATTORNEY, Lindsey Cohan for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-884, [ # 3535267-2 ], ADDED.[3535384] [23-884] [Entered: 06/29/2023 07:57 AM] |
Filing 75 ELECTRONIC INDEX, in lieu of record, FILED.[3535383] [23-879] [Entered: 06/29/2023 07:50 AM] |
Filing 73 ATTORNEY, Joseph W. Martini for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-879, [ # 3534237-2 ], ADDED.[3535381] [23-879] [Entered: 06/29/2023 07:36 AM] |
Filing 72 ATTORNEY, Anand Agneshwar for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-879, [ # 3534393-2 ], ADDED.[3535380] [23-879] [Entered: 06/29/2023 07:33 AM] |
Filing 71 ATTORNEY, Daniel S. Pariser for Sanofi US Services Inc. Sanofi-Aventis U.S. LLC, in case 23-879, [ # 3534406-2 ], ADDED.[3535379] [23-879] [Entered: 06/29/2023 07:10 AM] |
Filing 70 ATTORNEY, Robert R. Simpson for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-879, [ # 3534423-2 ], ADDED.[3535378] [23-879] [Entered: 06/29/2023 07:07 AM] |
Filing 69 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-879, [ # 3534438-2 ], ADDED.[3535377] [23-879] [Entered: 06/29/2023 07:05 AM] |
Filing 68 DEFECTIVE DOCUMENT, Form C, [ # 3534457-2 ], on behalf of Appellant Pfizer, Inc., FILED.[3535376] [23-879] [Entered: 06/29/2023 06:56 AM] |
Filing 67 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-879, [ # 3534466-2 ], ADDED.[3535375] [23-879] [Entered: 06/29/2023 06:53 AM] |
Filing 66 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-879, [ # 3535100-2 ], ADDED.[3535374] [23-879] [Entered: 06/29/2023 06:45 AM] |
Filing 98 ELECTRONIC INDEX, in lieu of record, FILED.[3535501] [23-883] [Entered: 06/29/2023 09:49 AM] |
Filing 65 ELECTRONIC INDEX, in lieu of record, FILED.[3535332] [23-878] [Entered: 06/28/2023 08:42 PM] |
Filing 64 ELECTRONIC INDEX, in lieu of record, FILED.[3535331] [23-881] [Entered: 06/28/2023 08:37 PM] |
Filing 63 ELECTRONIC INDEX, in lieu of record, FILED.[3535324] [23-885] [Entered: 06/28/2023 08:25 PM] |
Filing 62 ELECTRONIC INDEX, in lieu of record, FILED.[3535323] [23-882] [Entered: 06/28/2023 08:22 PM] |
Filing 61 CURED DEFECTIVE FORM C AND FORM D, [ # 3535159-2 ], [ # 3535161-2 ], on behalf of Appellants Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3535321] [23-885] [Entered: 06/28/2023 08:20 PM] |
Filing 60 ATTORNEY, Robert R. Simpson for Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, in case 23-885, [ # 3535245-2 ], ADDED.[3535320] [23-885] [Entered: 06/28/2023 08:19 PM] |
Filing 59 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-885, [ # 3535119-2 ], ADDED.[3535319] [23-885] [Entered: 06/28/2023 08:18 PM] |
Filing 58 CURED DEFECTIVE FORM C AND FORM D, [ # 3535165-2 ], [ # 3535173-2 ], on behalf of Appellants Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3535316] [23-882] [Entered: 06/28/2023 08:07 PM] |
Filing 57 ATTORNEY, Robert R. Simpson for Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, in case 23-882, [ # 3535240-2 ], ADDED.[3535315] [23-882] [Entered: 06/28/2023 08:04 PM] |
Filing 56 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-882, [ # 3535114-2 ], ADDED.[3535294] [23-882] [Entered: 06/28/2023 05:54 PM] |
Filing 55 ELECTRONIC INDEX, in lieu of record, FILED.[3535207] [23-880] [Entered: 06/28/2023 04:17 PM] |
Filing 54 ELECTRONIC INDEX, in lieu of record, FILED.[3535198] [23-877] [Entered: 06/28/2023 04:03 PM] |
Filing 53 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/28/2023 by CM/ECF. [3535083] [23-877] [Entered: 06/28/2023 03:04 PM] |
Filing 52 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-880, [ # 3534560-2 ], ADDED.[3534947] [23-880] [Entered: 06/28/2023 12:19 PM] |
Filing 51 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-880, [ # 3534440-2 ], ADDED.[3534942] [23-880] [Entered: 06/28/2023 12:17 PM] |
Filing 47 DEFECTIVE DOCUMENT, Form D, [ # 3534353-2 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3534931] [23-880] [Entered: 06/28/2023 12:04 PM] |
Filing 45 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-877, [ # 25 ], ADDED.[3534920] [23-877] [Entered: 06/28/2023 11:50 AM] |
Filing 43 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-877, [ # 20 ], ADDED.[3534912] [23-877] [Entered: 06/28/2023 11:44 AM] |
Filing 41 ATTORNEY, Lindsey Cohan, [ # 3534604-2 ], in place of attorney Robert R. Simpson, SUBSTITUTED.[3534669] [23-885] [Entered: 06/27/2023 10:58 PM] |
Filing 40 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-885, [ # 3534597-2 ], ADDED.[3534668] [23-885] [Entered: 06/27/2023 10:55 PM] |
Filing 39 ATTORNEY, Daniel S. Pariser for Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, in case 23-885, [ # 3534493-2 ], ADDED.[3534667] [23-885] [Entered: 06/27/2023 10:49 PM] |
Filing 38 DEFECTIVE DOCUMENT, Form D, [ # 3534486-2 ], [ # 3534491-2 ], on behalf of Appellants Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3534665] [23-885] [Entered: 06/27/2023 10:42 PM] |
Filing 37 DEFECTIVE DOCUMENT, Form C, [ # 3534594-2 ], on behalf of Appellants Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3534664] [23-885] [Entered: 06/27/2023 10:36 PM] |
Filing 36 ATTORNEY, Anand Agneshwar, [ # 3534480-2 ], in place of attorney Daniel S. Pariser, SUBSTITUTED.[3534663] [23-885] [Entered: 06/27/2023 10:32 PM] |
Filing 35 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, in case 23-885, [ # 3534461-2 ], ADDED.[3534662] [23-885] [Entered: 06/27/2023 10:29 PM] |
Filing 34 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 3534421-2 ], on behalf of Appellants GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3534659] [23-885] [Entered: 06/27/2023 10:23 PM] |
Filing 33 ATTORNEY, Lindsey Cohan, [ # 3534601-2 ], in place of attorney Robert R. Simpson, SUBSTITUTED.[3534656] [23-882] [Entered: 06/27/2023 10:08 PM] |
Filing 32 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-882, [ # 3534590-2 ], ADDED.[3534653] [23-882] [Entered: 06/27/2023 10:02 PM] |
Filing 31 DEFECTIVE DOCUMENT, Form D, [ # 3534462-2 ], on behalf of Appellants Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3534650] [23-882] [Entered: 06/27/2023 09:50 PM] |
Filing 30 DEFECTIVE DOCUMENT, Form C, [ # 3534456-2 ], on behalf of Appellants Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3534649] [23-882] [Entered: 06/27/2023 09:43 PM] |
Filing 29 ATTORNEY, Daniel S. Pariser for Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, in case 23-882, [ # 3534464-2 ], ADDED.[3534645] [23-882] [Entered: 06/27/2023 09:21 PM] |
Filing 28 ATTORNEY, Lauren R. Greenspoon for Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, in case 23-882, [ # 3534447-2 ], ADDED.[3534644] [23-882] [Entered: 06/27/2023 09:16 PM] |
Filing 27 ATTORNEY, Anand Agneshwar, [ # 3534446-2 ], in place of attorney Daniel S. Pariser, SUBSTITUTED.[3534642] [23-882] [Entered: 06/27/2023 09:13 PM] |
Filing 26 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 3534411-2 ], on behalf of Appellants GlaxoSmithKline LLC and Glaxosmithkline Holdings (Americas), Inc., FILED.[3534639] [23-882] [Entered: 06/27/2023 08:58 PM] |
Filing 25 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF. [3534515] [23-877] [Entered: 06/27/2023 04:48 PM] |
Filing 24 FORM D, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534506] [23-877] [Entered: 06/27/2023 04:42 PM] |
Filing 23 FORM C, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534505] [23-877] [Entered: 06/27/2023 04:41 PM] |
Filing 22 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534500] [23-877] [Entered: 06/27/2023 04:38 PM] |
Filing 21 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellee Beth Bacher, FILED. Service date 06/27/2023 by CM/ECF, email.[3534485] [23-877] [Entered: 06/27/2023 04:32 PM] |
Filing 20 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534431] [23-877] [Entered: 06/27/2023 03:58 PM] |
Filing 19 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534388] [23-877] [Entered: 06/27/2023 03:22 PM] |
Filing 18 FORM D, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534276] [23-877] [Entered: 06/27/2023 01:57 PM] |
Filing 17 FORM C, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534275] [23-877] [Entered: 06/27/2023 01:56 PM] |
Filing 16 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534274] [23-877] [Entered: 06/27/2023 01:55 PM] |
Filing 15 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534268] [23-877] [Entered: 06/27/2023 01:49 PM] |
Filing 14 ATTORNEY, Joseph W. Martini for Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, in case 23-885, [ # 3534256-2 ], ADDED.[3534263] [23-885] [Entered: 06/27/2023 01:47 PM] |
Filing 13 ATTORNEY, Joseph W. Martini for Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, in case 23-882, [ # 3534252-2 ], ADDED.[3534261] [23-882] [Entered: 06/27/2023 01:46 PM] |
Filing 12 FORM D, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534253] [23-877] [Entered: 06/27/2023 01:37 PM] |
Filing 11 FORM C, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534242] [23-877] [Entered: 06/27/2023 01:33 PM] |
Filing 10 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Sanofi-Aventis U.S. LLC and Sanofi US Services Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534231] [23-877] [Entered: 06/27/2023 01:27 PM] |
Filing 9 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534230] [23-877] [Entered: 06/27/2023 01:21 PM] |
Filing 8 FORM D, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534198] [23-877] [Entered: 06/27/2023 12:49 PM] |
Filing 7 FORM C, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534195] [23-877] [Entered: 06/27/2023 12:48 PM] |
Filing 6 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534186] [23-877] [Entered: 06/27/2023 12:45 PM] |
Filing 5 CASE CALENDARING, for the week of 09/18/2023, A, PROPOSED.[3531137] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/20/2023 01:10 PM] |
Filing 4 ORDER, dated 06/16/2023, setting Appellant's brief due date as July 17, 2023 and Appellees' brief due date as August 17, 2023. The reply brief is due by August 28, 2023. The Clerk is directed to set the appeal for argument as early as the week of September 18, 2023., FILED.[3530582] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/16/2023 04:28 PM] |
Filing 2 DISTRICT COURT ORDER, dated 01/17/2023, RECEIVED.[3528512] [23-877] [Entered: 06/13/2023 12:48 PM] |
Filing 1 NOTICE OF CIVIL APPEAL, with district court docket, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. [3528507] [23-877] [Entered: 06/13/2023 12:44 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.